Blog
RSS FeedPosted by Michael Wonder on 14 Jul 2017
Additional Public Summary Documents - PBAC March 2017 meeting
14 July 2017 - The Public Summary Documents (first time rejections and deferrals) from the March 2017 PBAC\ meeting are now ...
Posted by Michael Wonder on 05 Jul 2017
Serious concerns over true intentions of review
5 July 2017 - Nearly two weeks on from the release of the Interim Report of the Pharmacy Remuneration and ...
Posted by Michael Wonder on 01 Jul 2017
Public Summary Documents - March 2017 PBAC meeting
30 June 2017 - The public summary documents from the March 2017 PBAC meeting are now available. ...
Posted by Michael Wonder on 27 Jun 2017
Guild caned on pharmacy review ban
27 June 2017 - The Pharmacy Guild of Australia has been criticised over attempts to boycott an independent review of ...
Posted by Michael Wonder on 27 Jun 2017
Interim report ‘a step backwards’
27 June 2017 - Peak bodies have come together to highlight potential problems with King Review suggestions. ...
Posted by Michael Wonder on 26 Jun 2017
‘Overcharging’ claims give false impression
26 June 2017 - Guild condemns PBS price fixing suggestion as article accuses pharmacies of overcharging. ...
Posted by Michael Wonder on 26 Jun 2017
Has the interim report considered long term supply chain impacts?
23 June 2017 - Medicines Australia welcomes the release of the Interim Report of Pharmacy Review but has concerns about ...
Posted by Michael Wonder on 25 Jun 2017
Chemists have been overcharging customers for medicines a government review finds
24 June 2017 - The price of the same PBS medicine can vary by up to 200% from shop to ...
Posted by Michael Wonder on 22 Jun 2017
Release of the review's interim report
22 June 2017 - The Review is pleased to present the interim report for the Review of Pharmacy Remuneration and ...
Posted by Michael Wonder on 29 May 2017
Draft report for the post-market review of COPD medicines
29 May 2017 - The draft report for the post-market review of chronic obstructive pulmonary disease medicines is available for ...
Posted by Michael Wonder on 24 May 2017
A message from the Minister
24 May 2017 - It is my pleasure to update you on the agreement the Government has reached with the ...
Posted by Michael Wonder on 19 May 2017
Post-market review of ezetimibe – notice of public consultation
19 May 2017 - The public consultation on the revised draft ezetimibe post-market review report to the PBAC will open ...
Posted by Michael Wonder on 31 Mar 2017
Biosimilar awareness initiative - April 2017 update
1 April 2017 - The Initiative was announced in May 2015 as part of the Pharmaceutical Benefits Scheme Access and Sustainability ...
Posted by Michael Wonder on 23 Mar 2017
Public summary document for Keytruda (pembrolizumab)
22 March 2017 - The public summary document for pembrolizumab for the treatment of patients with non-small-cell lung cancer from the ...
Posted by Michael Wonder on 18 Mar 2017
Additional public summary documents from the November 2016 PBAC meeting
17 March 2017 - The public summary documents (first time rejections and deferrals) from the November 2016 PBAC meeting are ...